Blood bank reagents
Ended Awarded Last action
- Contract number
- 36C25724N0228
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,303
Award facts
- Contract value 100% obligated
- $7,302.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown, PA 18940, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$80 | |
| Original award | $7,383 |
About this award
Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., was awarded a $7,302.55 firm fixed price Blanket Purchase Agreement call by Veterans Integrated Service Network 17 on May 1, 2024, for blood bank reagents with an ultimate completion date of April 30, 2025. This contract, issued without set-aside designation, leverages Alba Bioscience's established position as a specialized supplier of immunohematology products to the Department of Veterans Affairs. The award represents a task order under Alba Bioscience's existing Indefinite Delivery/Indefinite Quantity agreements on the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, which enable VA medical facilities nationwide to efficiently procure critical blood banking supplies through streamlined procurement processes.
Alba Bioscience delivers a comprehensive portfolio of blood banking materials including ALBACLONE monoclonal antibodies targeting various blood group antigens, antibody identification and screening panels, quality control kits, and specialized additives and cell reagents essential for transfusion services and diagnostic testing. As a non-small business vendor competing on specialized capabilities rather than set-aside preferences, Alba Bioscience has sustained demand across multiple Veterans Integrated Service Networks, the Defense Logistics Agency's Medical Supply Chain division, and other federal healthcare agencies. The firm's deliverables support critical VA operations including blood typing, antibody screening, and transfusion services at medical facilities throughout the integrated healthcare system.
Quick answers
Who was awarded contract 36C25724N0228?
36C25724N0228 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on May 1, 2024.
How much is contract 36C25724N0228 worth?
The government has obligated $7,303 on 36C25724N0228.
Is contract 36C25724N0228 an order under another contract?
Yes. 36C25724N0228 is a BPA call under 36F79721D0259-36C25722A0011, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25724N0228 competed?
The extent of competition for 36C25724N0228 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award